This demonstrates that ZFP36L1 expression is sufficient to block ASCL1 neuroendocrine differentiation and cellular proliferation in SCLC and that these phenotypes require ZFP36L1’s mRNA-binding activity. The gene discussed is ASCL1; the disease is small cell lung carcinoma.